The global Antipsychotic Medicine market was valued at million in 2024 and is projected to reach US$ million by 2032, at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
We have surveyed the Antipsychotic Medicine companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Antipsychotic Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antipsychotic Medicine. This report contains market size and forecasts of Antipsychotic Medicine in global, including the following market information:
Global Antipsychotic Medicine market revenue, 2020-2025, 2026-2032, ($ millions)
Global top five Antipsychotic Medicine companies in 2024 (%)
Total Market by Segment:
Global Antipsychotic Medicine market, by Type, 2020-2025, 2026-2032 ($ millions)
Global Antipsychotic Medicine market segment percentages, by Type, 2024 (%)
Oral Antipsychotics
Injectable Antipsychotics
Global Antipsychotic Medicine market, by Application, 2020-2025, 2026-2032 ($ millions)
Global Antipsychotic Medicine market segment percentages, by Application, 2024 (%)
Hospital Pharmacy
Clinic Pharmacy
Online Pharmacy
Global Antipsychotic Medicine market, by region and country, 2020-2025, 2026-2032 ($ millions)
Global Antipsychotic Medicine market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Antipsychotic Medicine revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Antipsychotic Medicine revenues share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
Johnson and Johnson
Eli Lilly
Bristol-Myers Squibb
AstraZeneca
Novartis
Allergan
Pfizer
GlaxoSmithKline
Otsuka Pharma
Sumitomo Dainippon
Alkermes
Vanda Pharma
Outline of Major Chapters:
Chapter 1: Introduces the definition of Antipsychotic Medicine, market overview.
Chapter 2: Global Antipsychotic Medicine market size in revenue.
Chapter 3: Detailed analysis of Antipsychotic Medicine company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Antipsychotic Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Antipsychotic Medicine Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global Antipsychotic Medicine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Antipsychotic Medicine Overall Market Size
2.1 Global Antipsychotic Medicine Market Size: 2024 VS 2032
2.2 Global Antipsychotic Medicine Market Size, Prospects & Forecasts: 2020-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Antipsychotic Medicine Players in Global Market
3.2 Top Global Antipsychotic Medicine Companies Ranked by Revenue
3.3 Global Antipsychotic Medicine Revenue by Companies
3.4 Top 3 and Top 5 Antipsychotic Medicine Companies in Global Market, by Revenue in 2024
3.5 Global Companies Antipsychotic Medicine Product Type
3.6 Tier 1, Tier 2, and Tier 3 Antipsychotic Medicine Players in Global Market
3.6.1 List of Global Tier 1 Antipsychotic Medicine Companies
3.6.2 List of Global Tier 2 and Tier 3 Antipsychotic Medicine Companies
4 Sights by Product
4.1 Overview
4.1.1 Segmentation by Type - Global Antipsychotic Medicine Market Size Markets, 2024 & 2032
4.1.2 Oral Antipsychotics
4.1.3 Injectable Antipsychotics
4.2 Segmentation by Type - Global Antipsychotic Medicine Revenue & Forecasts
4.2.1 Segmentation by Type - Global Antipsychotic Medicine Revenue, 2020-2025
4.2.2 Segmentation by Type - Global Antipsychotic Medicine Revenue, 2026-2032
4.2.3 Segmentation by Type - Global Antipsychotic Medicine Revenue Market Share, 2020-2032
5 Sights by Application
5.1 Overview
5.1.1 Segmentation by Application - Global Antipsychotic Medicine Market Size, 2024 & 2032
5.1.2 Hospital Pharmacy
5.1.3 Clinic Pharmacy
5.1.4 Online Pharmacy
5.2 Segmentation by Application - Global Antipsychotic Medicine Revenue & Forecasts
5.2.1 Segmentation by Application - Global Antipsychotic Medicine Revenue, 2020-2025
5.2.2 Segmentation by Application - Global Antipsychotic Medicine Revenue, 2026-2032
5.2.3 Segmentation by Application - Global Antipsychotic Medicine Revenue Market Share, 2020-2032
6 Sights by Region
6.1 By Region - Global Antipsychotic Medicine Market Size, 2024 & 2032
6.2 By Region - Global Antipsychotic Medicine Revenue & Forecasts
6.2.1 By Region - Global Antipsychotic Medicine Revenue, 2020-2025
6.2.2 By Region - Global Antipsychotic Medicine Revenue, 2026-2032
6.2.3 By Region - Global Antipsychotic Medicine Revenue Market Share, 2020-2032
6.3 North America
6.3.1 By Country - North America Antipsychotic Medicine Revenue, 2020-2032
6.3.2 United States Antipsychotic Medicine Market Size, 2020-2032
6.3.3 Canada Antipsychotic Medicine Market Size, 2020-2032
6.3.4 Mexico Antipsychotic Medicine Market Size, 2020-2032
6.4 Europe
6.4.1 By Country - Europe Antipsychotic Medicine Revenue, 2020-2032
6.4.2 Germany Antipsychotic Medicine Market Size, 2020-2032
6.4.3 France Antipsychotic Medicine Market Size, 2020-2032
6.4.4 U.K. Antipsychotic Medicine Market Size, 2020-2032
6.4.5 Italy Antipsychotic Medicine Market Size, 2020-2032
6.4.6 Russia Antipsychotic Medicine Market Size, 2020-2032
6.4.7 Nordic Countries Antipsychotic Medicine Market Size, 2020-2032
6.4.8 Benelux Antipsychotic Medicine Market Size, 2020-2032
6.5 Asia
6.5.1 By Region - Asia Antipsychotic Medicine Revenue, 2020-2032
6.5.2 China Antipsychotic Medicine Market Size, 2020-2032
6.5.3 Japan Antipsychotic Medicine Market Size, 2020-2032
6.5.4 South Korea Antipsychotic Medicine Market Size, 2020-2032
6.5.5 Southeast Asia Antipsychotic Medicine Market Size, 2020-2032
6.5.6 India Antipsychotic Medicine Market Size, 2020-2032
6.6 South America
6.6.1 By Country - South America Antipsychotic Medicine Revenue, 2020-2032
6.6.2 Brazil Antipsychotic Medicine Market Size, 2020-2032
6.6.3 Argentina Antipsychotic Medicine Market Size, 2020-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Antipsychotic Medicine Revenue, 2020-2032
6.7.2 Turkey Antipsychotic Medicine Market Size, 2020-2032
6.7.3 Israel Antipsychotic Medicine Market Size, 2020-2032
6.7.4 Saudi Arabia Antipsychotic Medicine Market Size, 2020-2032
6.7.5 UAE Antipsychotic Medicine Market Size, 2020-2032
7 Companies Profiles
7.1 Johnson and Johnson
7.1.1 Johnson and Johnson Corporate Summary
7.1.2 Johnson and Johnson Business Overview
7.1.3 Johnson and Johnson Antipsychotic Medicine Major Product Offerings
7.1.4 Johnson and Johnson Antipsychotic Medicine Revenue in Global Market (2020-2025)
7.1.5 Johnson and Johnson Key News & Latest Developments
7.2 Eli Lilly
7.2.1 Eli Lilly Corporate Summary
7.2.2 Eli Lilly Business Overview
7.2.3 Eli Lilly Antipsychotic Medicine Major Product Offerings
7.2.4 Eli Lilly Antipsychotic Medicine Revenue in Global Market (2020-2025)
7.2.5 Eli Lilly Key News & Latest Developments
7.3 Bristol-Myers Squibb
7.3.1 Bristol-Myers Squibb Corporate Summary
7.3.2 Bristol-Myers Squibb Business Overview
7.3.3 Bristol-Myers Squibb Antipsychotic Medicine Major Product Offerings
7.3.4 Bristol-Myers Squibb Antipsychotic Medicine Revenue in Global Market (2020-2025)
7.3.5 Bristol-Myers Squibb Key News & Latest Developments
7.4 AstraZeneca
7.4.1 AstraZeneca Corporate Summary
7.4.2 AstraZeneca Business Overview
7.4.3 AstraZeneca Antipsychotic Medicine Major Product Offerings
7.4.4 AstraZeneca Antipsychotic Medicine Revenue in Global Market (2020-2025)
7.4.5 AstraZeneca Key News & Latest Developments
7.5 Novartis
7.5.1 Novartis Corporate Summary
7.5.2 Novartis Business Overview
7.5.3 Novartis Antipsychotic Medicine Major Product Offerings
7.5.4 Novartis Antipsychotic Medicine Revenue in Global Market (2020-2025)
7.5.5 Novartis Key News & Latest Developments
7.6 Allergan
7.6.1 Allergan Corporate Summary
7.6.2 Allergan Business Overview
7.6.3 Allergan Antipsychotic Medicine Major Product Offerings
7.6.4 Allergan Antipsychotic Medicine Revenue in Global Market (2020-2025)
7.6.5 Allergan Key News & Latest Developments
7.7 Pfizer
7.7.1 Pfizer Corporate Summary
7.7.2 Pfizer Business Overview
7.7.3 Pfizer Antipsychotic Medicine Major Product Offerings
7.7.4 Pfizer Antipsychotic Medicine Revenue in Global Market (2020-2025)
7.7.5 Pfizer Key News & Latest Developments
7.8 GlaxoSmithKline
7.8.1 GlaxoSmithKline Corporate Summary
7.8.2 GlaxoSmithKline Business Overview
7.8.3 GlaxoSmithKline Antipsychotic Medicine Major Product Offerings
7.8.4 GlaxoSmithKline Antipsychotic Medicine Revenue in Global Market (2020-2025)
7.8.5 GlaxoSmithKline Key News & Latest Developments
7.9 Otsuka Pharma
7.9.1 Otsuka Pharma Corporate Summary
7.9.2 Otsuka Pharma Business Overview
7.9.3 Otsuka Pharma Antipsychotic Medicine Major Product Offerings
7.9.4 Otsuka Pharma Antipsychotic Medicine Revenue in Global Market (2020-2025)
7.9.5 Otsuka Pharma Key News & Latest Developments
7.10 Sumitomo Dainippon
7.10.1 Sumitomo Dainippon Corporate Summary
7.10.2 Sumitomo Dainippon Business Overview
7.10.3 Sumitomo Dainippon Antipsychotic Medicine Major Product Offerings
7.10.4 Sumitomo Dainippon Antipsychotic Medicine Revenue in Global Market (2020-2025)
7.10.5 Sumitomo Dainippon Key News & Latest Developments
7.11 Alkermes
7.11.1 Alkermes Corporate Summary
7.11.2 Alkermes Business Overview
7.11.3 Alkermes Antipsychotic Medicine Major Product Offerings
7.11.4 Alkermes Antipsychotic Medicine Revenue in Global Market (2020-2025)
7.11.5 Alkermes Key News & Latest Developments
7.12 Vanda Pharma
7.12.1 Vanda Pharma Corporate Summary
7.12.2 Vanda Pharma Business Overview
7.12.3 Vanda Pharma Antipsychotic Medicine Major Product Offerings
7.12.4 Vanda Pharma Antipsychotic Medicine Revenue in Global Market (2020-2025)
7.12.5 Vanda Pharma Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Antipsychotic Medicine Market Opportunities & Trends in Global Market
Table 2. Antipsychotic Medicine Market Drivers in Global Market
Table 3. Antipsychotic Medicine Market Restraints in Global Market
Table 4. Key Players of Antipsychotic Medicine in Global Market
Table 5. Top Antipsychotic Medicine Players in Global Market, Ranking by Revenue (2024)
Table 6. Global Antipsychotic Medicine Revenue by Companies, (US$, Mn), 2020-2025
Table 7. Global Antipsychotic Medicine Revenue Share by Companies, 2020-2025
Table 8. Global Companies Antipsychotic Medicine Product Type
Table 9. List of Global Tier 1 Antipsychotic Medicine Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Antipsychotic Medicine Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segmentation by Type � Global Antipsychotic Medicine Revenue, (US$, Mn), 2024 & 2032
Table 12. Segmentation by Type - Global Antipsychotic Medicine Revenue (US$, Mn), 2020-2025
Table 13. Segmentation by Type - Global Antipsychotic Medicine Revenue (US$, Mn), 2026-2032
Table 14. Segmentation by Application� Global Antipsychotic Medicine Revenue, (US$, Mn), 2024 & 2032
Table 15. Segmentation by Application - Global Antipsychotic Medicine Revenue, (US$, Mn), 2020-2025
Table 16. Segmentation by Application - Global Antipsychotic Medicine Revenue, (US$, Mn), 2026-2032
Table 17. By Region� Global Antipsychotic Medicine Revenue, (US$, Mn), 2024 & 2032
Table 18. By Region - Global Antipsychotic Medicine Revenue, (US$, Mn), 2020-2025
Table 19. By Region - Global Antipsychotic Medicine Revenue, (US$, Mn), 2026-2032
Table 20. By Country - North America Antipsychotic Medicine Revenue, (US$, Mn), 2020-2025
Table 21. By Country - North America Antipsychotic Medicine Revenue, (US$, Mn), 2026-2032
Table 22. By Country - Europe Antipsychotic Medicine Revenue, (US$, Mn), 2020-2025
Table 23. By Country - Europe Antipsychotic Medicine Revenue, (US$, Mn), 2026-2032
Table 24. By Region - Asia Antipsychotic Medicine Revenue, (US$, Mn), 2020-2025
Table 25. By Region - Asia Antipsychotic Medicine Revenue, (US$, Mn), 2026-2032
Table 26. By Country - South America Antipsychotic Medicine Revenue, (US$, Mn), 2020-2025
Table 27. By Country - South America Antipsychotic Medicine Revenue, (US$, Mn), 2026-2032
Table 28. By Country - Middle East & Africa Antipsychotic Medicine Revenue, (US$, Mn), 2020-2025
Table 29. By Country - Middle East & Africa Antipsychotic Medicine Revenue, (US$, Mn), 2026-2032
Table 30. Johnson and Johnson Corporate Summary
Table 31. Johnson and Johnson Antipsychotic Medicine Product Offerings
Table 32. Johnson and Johnson Antipsychotic Medicine Revenue (US$, Mn) & (2020-2025)
Table 33. Johnson and Johnson Key News & Latest Developments
Table 34. Eli Lilly Corporate Summary
Table 35. Eli Lilly Antipsychotic Medicine Product Offerings
Table 36. Eli Lilly Antipsychotic Medicine Revenue (US$, Mn) & (2020-2025)
Table 37. Eli Lilly Key News & Latest Developments
Table 38. Bristol-Myers Squibb Corporate Summary
Table 39. Bristol-Myers Squibb Antipsychotic Medicine Product Offerings
Table 40. Bristol-Myers Squibb Antipsychotic Medicine Revenue (US$, Mn) & (2020-2025)
Table 41. Bristol-Myers Squibb Key News & Latest Developments
Table 42. AstraZeneca Corporate Summary
Table 43. AstraZeneca Antipsychotic Medicine Product Offerings
Table 44. AstraZeneca Antipsychotic Medicine Revenue (US$, Mn) & (2020-2025)
Table 45. AstraZeneca Key News & Latest Developments
Table 46. Novartis Corporate Summary
Table 47. Novartis Antipsychotic Medicine Product Offerings
Table 48. Novartis Antipsychotic Medicine Revenue (US$, Mn) & (2020-2025)
Table 49. Novartis Key News & Latest Developments
Table 50. Allergan Corporate Summary
Table 51. Allergan Antipsychotic Medicine Product Offerings
Table 52. Allergan Antipsychotic Medicine Revenue (US$, Mn) & (2020-2025)
Table 53. Allergan Key News & Latest Developments
Table 54. Pfizer Corporate Summary
Table 55. Pfizer Antipsychotic Medicine Product Offerings
Table 56. Pfizer Antipsychotic Medicine Revenue (US$, Mn) & (2020-2025)
Table 57. Pfizer Key News & Latest Developments
Table 58. GlaxoSmithKline Corporate Summary
Table 59. GlaxoSmithKline Antipsychotic Medicine Product Offerings
Table 60. GlaxoSmithKline Antipsychotic Medicine Revenue (US$, Mn) & (2020-2025)
Table 61. GlaxoSmithKline Key News & Latest Developments
Table 62. Otsuka Pharma Corporate Summary
Table 63. Otsuka Pharma Antipsychotic Medicine Product Offerings
Table 64. Otsuka Pharma Antipsychotic Medicine Revenue (US$, Mn) & (2020-2025)
Table 65. Otsuka Pharma Key News & Latest Developments
Table 66. Sumitomo Dainippon Corporate Summary
Table 67. Sumitomo Dainippon Antipsychotic Medicine Product Offerings
Table 68. Sumitomo Dainippon Antipsychotic Medicine Revenue (US$, Mn) & (2020-2025)
Table 69. Sumitomo Dainippon Key News & Latest Developments
Table 70. Alkermes Corporate Summary
Table 71. Alkermes Antipsychotic Medicine Product Offerings
Table 72. Alkermes Antipsychotic Medicine Revenue (US$, Mn) & (2020-2025)
Table 73. Alkermes Key News & Latest Developments
Table 74. Vanda Pharma Corporate Summary
Table 75. Vanda Pharma Antipsychotic Medicine Product Offerings
Table 76. Vanda Pharma Antipsychotic Medicine Revenue (US$, Mn) & (2020-2025)
Table 77. Vanda Pharma Key News & Latest Developments
List of Figures
Figure 1. Antipsychotic Medicine Product Picture
Figure 2. Antipsychotic Medicine Segment by Type in 2024
Figure 3. Antipsychotic Medicine Segment by Application in 2024
Figure 4. Global Antipsychotic Medicine Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global Antipsychotic Medicine Market Size: 2024 VS 2032 (US$, Mn)
Figure 7. Global Antipsychotic Medicine Revenue: 2020-2032 (US$, Mn)
Figure 8. The Top 3 and 5 Players Market Share by Antipsychotic Medicine Revenue in 2024
Figure 9. Segmentation by Type � Global Antipsychotic Medicine Revenue, (US$, Mn), 2024 & 2032
Figure 10. Segmentation by Type - Global Antipsychotic Medicine Revenue Market Share, 2020-2032
Figure 11. Segmentation by Application � Global Antipsychotic Medicine Revenue, (US$, Mn), 2024 & 2032
Figure 12. Segmentation by Application - Global Antipsychotic Medicine Revenue Market Share, 2020-2032
Figure 13. By Region - Global Antipsychotic Medicine Revenue Market Share, 2020-2032
Figure 14. By Country - North America Antipsychotic Medicine Revenue Market Share, 2020-2032
Figure 15. United States Antipsychotic Medicine Revenue, (US$, Mn), 2020-2032
Figure 16. Canada Antipsychotic Medicine Revenue, (US$, Mn), 2020-2032
Figure 17. Mexico Antipsychotic Medicine Revenue, (US$, Mn), 2020-2032
Figure 18. By Country - Europe Antipsychotic Medicine Revenue Market Share, 2020-2032
Figure 19. Germany Antipsychotic Medicine Revenue, (US$, Mn), 2020-2032
Figure 20. France Antipsychotic Medicine Revenue, (US$, Mn), 2020-2032
Figure 21. U.K. Antipsychotic Medicine Revenue, (US$, Mn), 2020-2032
Figure 22. Italy Antipsychotic Medicine Revenue, (US$, Mn), 2020-2032
Figure 23. Russia Antipsychotic Medicine Revenue, (US$, Mn), 2020-2032
Figure 24. Nordic Countries Antipsychotic Medicine Revenue, (US$, Mn), 2020-2032
Figure 25. Benelux Antipsychotic Medicine Revenue, (US$, Mn), 2020-2032
Figure 26. By Region - Asia Antipsychotic Medicine Revenue Market Share, 2020-2032
Figure 27. China Antipsychotic Medicine Revenue, (US$, Mn), 2020-2032
Figure 28. Japan Antipsychotic Medicine Revenue, (US$, Mn), 2020-2032
Figure 29. South Korea Antipsychotic Medicine Revenue, (US$, Mn), 2020-2032
Figure 30. Southeast Asia Antipsychotic Medicine Revenue, (US$, Mn), 2020-2032
Figure 31. India Antipsychotic Medicine Revenue, (US$, Mn), 2020-2032
Figure 32. By Country - South America Antipsychotic Medicine Revenue Market Share, 2020-2032
Figure 33. Brazil Antipsychotic Medicine Revenue, (US$, Mn), 2020-2032
Figure 34. Argentina Antipsychotic Medicine Revenue, (US$, Mn), 2020-2032
Figure 35. By Country - Middle East & Africa Antipsychotic Medicine Revenue Market Share, 2020-2032
Figure 36. Turkey Antipsychotic Medicine Revenue, (US$, Mn), 2020-2032
Figure 37. Israel Antipsychotic Medicine Revenue, (US$, Mn), 2020-2032
Figure 38. Saudi Arabia Antipsychotic Medicine Revenue, (US$, Mn), 2020-2032
Figure 39. UAE Antipsychotic Medicine Revenue, (US$, Mn), 2020-2032
Figure 40. Johnson and Johnson Antipsychotic Medicine Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 41. Eli Lilly Antipsychotic Medicine Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 42. Bristol-Myers Squibb Antipsychotic Medicine Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 43. AstraZeneca Antipsychotic Medicine Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 44. Novartis Antipsychotic Medicine Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 45. Allergan Antipsychotic Medicine Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 46. Pfizer Antipsychotic Medicine Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 47. GlaxoSmithKline Antipsychotic Medicine Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 48. Otsuka Pharma Antipsychotic Medicine Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 49. Sumitomo Dainippon Antipsychotic Medicine Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 50. Alkermes Antipsychotic Medicine Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 51. Vanda Pharma Antipsychotic Medicine Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
